Integrant targets cartilage repair with AI-biologics platform
· tamra sami
AI Briefing
- • Integrant Pty Ltd develops AI-biologics platform to regenerate cartilage and preserve joint function.
- • Company aims to replace joint replacement surgery with cartilage repair.
- • Platform combines biologics, medical devices, and AI for osteoarthritis treatment.
Context
Integrant Pty Ltd is developing a platform to regenerate cartilage and preserve joint function. The company combines biologics, medical devices, and artificial intelligence to achieve this goal.
The company's platform targets osteoarthritis, a condition where cartilage deteriorates and pain worsens, often leading to joint replacement surgery.
Advertisement